Novai Company
Novai is a disruptive British biotech start-up with an AI supported retinal biomarker for use in glaucoma and AMD clinical trials.
Funding Status:
Seed
Industry:
Aging Biomarkers
Investors Number:
2
Last Funding Date:
2023-01-24
Founded Date:
2020-02-12
Headquarters:
Reading, Reading, United Kingdom
Total Funding:
5328528
Last Funding Type:
Seed
Employee Number:
11-50